摘要
目的观察参苓白术散加减治疗老年社区获得性肺炎(CAP)的临床疗效。方法选取2014年5月—2015年5月在广元市第三人民医院中医科住院治疗的老年CAP患者76例,采用摸球法将患者分为对照组和试验组,各38例。对照组患者采用常规西医治疗,试验组患者在常规西药治疗基础上联合参苓白术散加减治疗,连续治疗14 d为1个疗程。比较两组患者临床疗效、治疗前后中医证候积分及治疗期间不良反应发生情况。结果试验组患者临床疗效优于对照组(P<0.05)。治疗前两组患者中医证候积分比较,差异无统计学意义(P>0.05);治疗后试验组患者中医证候积分低于对照组(P<0.05)。治疗期间两组患者均未出现严重不良反应。结论参苓白术散加减治疗老年CAP的临床疗效确切,能有效改善患者临床症状,且安全性较高。
Objective To observe the clinical effect of shenling baishu powders in treating aged patients with community- acquired pneumonia. Methods From May 2014 to May 2015,a total of aged inpatients with community- acquired pneumonia were selected in the Department of Traditional Chinese Medicine,the Third People’s Hospital of Guangyuan,and they were divided into control group and test group by lot- drawing,each of 38 cases. Patients of control group received conventional Western medicine,while patients of test group received extra shenling baishu powders based on conventional Western medicine,both groups continuously treated by 14 days as a course. Clinical effect, TCM score before treatment and after treatment,incidence of adverse reactions during treatment were compared between the two groups. Results The clinical effect of test group was statistically significantly better than that of control group（ P 〈 0. 05）. No statistically significant differences of TCM score was found between the two groups before treatment（ P 〉 0. 05）,while TCM score of test group was statistically significantly lower than that of control group after treatment（ P 〈 0. 05）. No one of the two groups occurred any serious adverse reactions during treatment. Conclusion Shenling baishu powders has certain clinical effect in treating aged patients with community- acquired pneumonia,can effectively relieve the clinical symptoms,and is safe.
出处
《实用心脑肺血管病杂志》
2016年第3期95-97,共3页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
社区获得性感染
老年人
参苓白术散
治疗结果
Community-acquired infections
Aged
Shenling baishu powder
Treatment outcome
